MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Edwards Lifesciences buys Embrella Cardiovascular for $43 million

Edwards Lifesciences buys Embrella Cardiovascular for $43 million

By

EW

Edwards Lifesciences Inc. (NYSE:EW) scooped up Embrella Cardiovascular for a cool $43 million.

Wayne, Pa.-based Embrella makes embolic protection devices used in coronary procedures such as transcatheter valve replacements. Edwards officials said the deal, which closed March 11, will bolster the company’s position in the hot transcatheter valve market.

The Embrella embolic deflector system received the CE Mark in Europe in May 2010. The device is “placed in the aorta through a sheath inserted in the right brachial or right radial artery. Its porous membrane allows blood flow to the brain while simultaneously deflecting embolic material,” according to a press release.

Listen to our podcast with Edwards CEO Michael Mussallem

Edwards has had its eyes on Embrella for at least two years. Embrella launched in late 2007 and raised just under $9 million in two funding rounds. The latest, a Series B round of $6.7 million, closed in August 2009. Edwards was an investor in that round, which was led by BioStar Ventures and the MedFocus Fund. Hatteras Venture Partners also participated in the round.

Embrella is led by industry veteran Jeffrey O’Donnell, who was CEO of PhotoMedex for 10 years before joining Embrella in 2009.

Edwards, which also maintained its earnings guidance of between $1.59 billion to $1.67 billion in sales for 2011, said recently that it plans to be an active acquirer of new technology this year.

“We plan to invest aggressively in our future. We’re going to be substantially increasing our R&D by 20 percent [in 2011] and we plan to continue to be a long-term investor,” CEO Michael Mussallem told MassDevice in an early January interview.

Edwards is aiming for a US launch of its Sapien transcatheter valve replacement this fall.

In case you missed it

RSS From Medical Design & Outsourcing

  • A closer look at a microrobot that could treat a rare brain malformation
    Los Angeles–based startup Bionaut Labs emerged from stealth mode earlier this year to announce its intent to use drug-filled microrobots to treat certain cancers. The company has now secured a humanitarian use device designation from FDA to use a microrobot known as BNL-201 to treat Dandy-Walker syndrome, a rare brain malformation. In 1914, neurosurgeon Walter… […]
  • Heraeus buys Mo-Sci and ETS Technology Holdings
    The Heraeus Group has a deal to acquire Mo-Sci Corp. and ETS Technology Holdings, the Germany-based conglomerate announced this week. Mo-Sci is a supplier of glass microspheres, fibers and powders for medical devices, while ETS is the developer of bioactive glass fiber wound care product Mirragen, an FDA-cleared resorbable synthetic skin substitute. The companies —… […]
  • Medical Alley appoints new CEO
    The Medical Alley Association announced today that it appointed Roberta Dressen as its new president and CEO. Dressen takes over the position previously held by Shaye Mandle since 2014 before he announced his departure for the Biotechnology Innovation Organization (BIO) in February. Steffen Hovard served as interim CEO in the time since then. Get the full… […]
  • Westfall Technik names Mark Gomulka as CEO
    Westfall Technik’s board of directors has nominated Mark Gomulka to lead the company. Gomulka joined the Las Vegas–based plastics manufacturer as SVP in January 2020. Before that, he led Flex’s medical and precision plastics operations for five years and earlier spent 15 years at Nypro in various global operational and leadership roles. In those positions… […]
  • The MedTech Conference by AdvaMed to be a mixture of in-person and virtual
    To hold an event or not to hold a live event. Medtech trade association AdvaMed chose both for The Medtech Conference, which takes place next week. The September 27–30 conference includes a mixture of virtual presentations and in-person events in Washington, D.C., and Minneapolis. AdvaMed CEO Scott Whitaker mentioned several conference agenda highlights during a… […]
  • Varta launches online battery monitoring feature
    Battery maker Varta has launched a cloud computing feature to let customers remotely monitor battery charging, health and the temperature of the battery management system. While Varta makes microbatteries for medical devices such as hearing aids, the new online monitoring dashboard is meant for its “Easy Block” and “Easy Blade” modular smart batteries. The smart… […]
  • Bionaut Labs wins humanitarian use device designation to treat rare pediatric brain disorder
    Microrobotics startup Bionaut Labs has announced that FDA has granted a humanitarian use device designation for the device known as BNL-201 to treat Dandy-Walker syndrome, a congenital brain malformation affecting the cerebellum. According to the National Organization for Rare Disorders, the syndrome affects one out of every 25,000 to 35,000 live births. There are currently… […]
  • Integer plans $30 million innovation and manufacturing facility in Galway
    Integer Holdings Corp. (NYSE: ITGR) plans to build a medical device innovation and manufacturing facility in the Parkmore East area of Galway, Ireland. Plano, Texas–based Integer said the initial phase of the project will total 60,000 square feet and a $30 million investment over the coming years, with construction scheduled from 2022 to late 2023… […]
  • Accu-Tube appoints Matthew Haddle as CEO
    Accu-Tube today announced that it has appointed Matthew Haddle as its new CEO. Prior to joining the Englewood, Colorado-based company, Haddle was GM of industrial coating services and equipment at Praxair Surface Technology. He has also held senior management positions at Albany Engineered Composites and Accellent. Get the full story on our sister site, Medical… […]
  • LightDeck picks GS Plastic Optics for COVID-19 test ramp up
    LightDeck Diagnostics has selected GS Plastic Optics to make optical components for its new COVID-19 antibody testing platform. Boulder, Colorado–based LightDeck developed a screening platform to deliver results as quickly as five minutes for SARS-CoV-2 ultra-rapid antigen and COVID-19 total antibody tests, using a laser waveguide with a consumable cartridge for each testing sample.  Rochester,… […]
  • Hologic’s first Global Women’s Health Index flags preventative care for improvement
    An estimated 1.5 billion women have not been tested in the past year for critical diseases, according to Hologic’s first Global Women’s Health Index. On behalf of diagnostic maker Hologic, the Gallup World Poll surveyed more than 60,000 women and girls (age 15 and older) across the world to measure action and attitudes about women’s… […]

Leave a Reply